Hidden factor in cancer treatment timing may affect survival, researchers say
Timing matters: Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.
23 Dec 16:53 · Fox News
last updated on 23 Dec 20:32